This study reports the in vivo bone regeneration using a newly developed porous bioactive and resorbable composite that is composed of bioactive glass (BG), collagen (COL), hyaluronic acid (HYA) and phosphatidylserine (PS), BG COL HYA PS.
In the 1999 Anitua [ 11] reported the preliminary clinical evidence of the beneficial effect of the use of P.R.P. in bone regeneration using plasmapheresis.
The present authors previously reported the fabrication of scaffolds for bone regeneration using non-porous PLGA/poly ethylene glycol) (PEG) microparticles that can be either implanted or injected and solidify at 37 °C.
These results demonstrate that it is possible to achieve bone regeneration using 30 times less rhBMP-2 than INFUSE®, the current clinical gold standard; thus, this work represents the first step of the development of a rhBMP-2 eluting material with immense clinical potential.
The purpose of this study was to evaluate the stability and viability of mandibular bone regeneration using a poly l-lactide) (poly l-lactide autogenous PLLAiculate cancellous bone and meshow (PCBM).
We then investigated the possibility of directing autologous MSC-mediated bone regeneration using a murine calvaria model.
The purpose of this study was to histologically and immunohistochemically evaluate bone regeneration using 3 different implant materials in rabbit mandibles and to compare the bone regenerative capability of these materials in an animal model.
Suppl 1. Tejeda-Montes, E. et al. Mineralization and bone regeneration using a bioactive elastin-like recombinamer membrane.
Stimulation of bone regeneration using growth factors is a promising approach for musculoskeletal regenerative engineering.
